RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Missed Opportunity... AgainAll I can say is that yes, , he is probably unfit in some areas for the job based upon our past experience with him but more importantly I do think there is a backroom deal that has been agreed to by a pharma (i.e. Merck) that has basically said to him, keep on doing what you are doing, fly under the radar for now, prove up the science and then we will fund you (if you need it ) to advance the science but we will eventually buy you out if you got the goods. No way to prove it...all my speculation but that's what I think is going to happen.